Lower Allele Frequency of TERT -rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk
Open Access
- 1 March 2026
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (3) , e2500446
Abstract
PURPOSE: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. The higher incidence and earlier onset of HCC in sub-Saharan Africa suggest a potential role for a genetic predisposition. This study evaluated the association of TERT -rs2242652-(A), a variant linked to lower HCC risk, with HCC in populations from Ghana, Nigeria, and Cameroon, compared with a population from the United States. METHODS: The study included 537 patients with HCC: United States (n = 348), Ghana (n = 79), Nigeria (n = 43), and Cameroon (n = 67). The control group had 2,872 cancer-free individuals: United States (n = 2,399), Ghana (n = 323), Nigeria (n = 85), and Cameroon (n = 65). Whole-exome sequencing was conducted using germline DNA, and data for TERT -rs2242652 were analyzed. Odds ratios (ORs) and 95% CIs were calculated using unconditional logistic regression. Chi-square tests assessed protective allele frequencies. RESULTS: In the US cohort, TERT -rs2242652 was significantly associated with lower HCC risk (OR, 0.75 [95% CI, 0.58 to 0.96]; P = .02), with an allele frequency of 18.8% (15.4% in HCC cases v 19.3% in controls). In the combined sub-Saharan African population, no significant association was observed, but there was a trend toward decreased HCC risk (OR, 0.80 [95% CI, 0.53 to 1.22]; P = .29), with an allele frequency of 12.2% (10.6% in HCC cases v 12.9% in controls). Separate analyses of Ghanaian, Nigerian, and Cameroonian populations showed similar nonsignificant trends. The protective allele frequency in the combined African populations was significantly lower than in the US cohort ( P < .0001). CONCLUSION: In sub-Saharan African populations, there was a lower frequency of the HCC protective allele TERT -rs2242652 compared with European Americans. These findings underscore the importance of multiethnic genetic studies in understanding population differences in HCC risk and developing prevention strategies.Keywords
This publication has 30 references indexed in Scilit:
- Lower Frequency of PNPLA3 Polymorphism in West African Populations and Divergent Associations With Hepatocellular CarcinomaGastro Hep Advances, 2025
- Mayo Clinic Tapestry StudyMayo Clinic Proceedings, 2024
- Germline Genetic Associations for Hepatobiliary CancersCellular and Molecular Gastroenterology and Hepatology, 2023
- Hepatocellular carcinomaThe Lancet, 2022
- Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan AfricaThe Lancet Gastroenterology & Hepatology, 2022
- Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetJournal of Hepatology, 2021
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresJournal of Hepatology, 2021
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus–related liver carcinogenesisTranslational Research, 2016
- Family history of liver cancer and hepatocellular carcinomaHepatology, 2011